ACCELERATED STABILITY TESTING OF ANTI-AGING CREAM: FORMATION OF MYRISTIC ACID AND STEARIC ACID AS DEGRADATION PRODUCTS
Objective: This study aimed to determine the stability of anti-aging cream using the accelerated stability test and calculating the levels of myristic
acid and stearic acid as degradation products.
Methods: Optimum conditions and validation methods for the mixture of myristic acid and stearic acid were determined to obtain a valid method for
determining the levels of degradation products in anti-aging cream. Derivatization was performed with the Lepage esterification method, which uses
methanol-toluene 4:1 (v/v) and acetyl chloride catalysts. The analysis was performed using gas chromatography (GC) Shimadzu GC-17A system with
an HP-1 column and flame ionization detection.
Results: The column temperature was 120Â°C, with an increase of 10Â°C/min (up to 160Â°C) followed by an increase of 3Â°C/min (up to 220Â°C;
maintained for 5 min) and an increase of 10Â°C/min (up to 260Â°C; maintained for 5 min). The injector and detector temperatures were 260Â°C and
280Â°C, respectively, with a flow rate of 1 mL/min. The retention times of myristic acid and stearic acid were 16.655 min and 28.169 min, respectively,
with tailing factor values of 0.734 and 0.943, respectively. Validation results fulfilled our acceptance criteria, which obtained linearity for myristic
acid at y=9.6483+190.78x, with a correlation coefficient (r) value of 0.9997, limit of detection (LOD)=0.0013 parts per million (ppm), and limit
of quantification (LOQ)=0.0042 ppm. The linearity for stearic acid was determined at y=17.163+106.22x, with a correlation coefficient (r) value
of 0.9998, LOD=0.0016 ppm, and LOQ=0.0053 ppm. Results of the anti-aging cream stability test indicated that the average remaining levels of
isopropyl myristate from 0 to 3 months were 99.6283%, 99.1995%, 98.2571%, and 97.1511%, respectively. The average remaining levels of glyceryl
monostearate were 99.6791%, 98.2881%, 96.2247%, and 93.7195% from 0 to 3 months, respectively.
Conclusion: The expiration date of the anti-aging cream product was then calculated using zero-order kinetics and determined to be 10 months and
Conf Ser: Mater Sci Eng 2015;87(1):1-5.
2. Srivastava DRS, Shah KP. Formulation and evaluation of novel
herbal anti-ageing formulation (gel-cream). World J Pharm Res
3. Weiss RA, Weiss MA. Evaluation of a novel anti-aging topical
formulation containing cycloastragenol, growth factors, peptides, and
antioxidants. J Drugs Dermatol 2014;13(9):1135-9.
4. Hahn HJ, Jung HJ, Schrammek-Drusios MC, Lee SN, Kim JH,
Kwon SB, et al. Instrumental evaluation of anti-aging effects of cosmetic
formulations containing palmitoyl peptides, Silybum marianum seed
oil, vitamin E and other functional ingredients on aged human skin.
Exp Ther Med 2016;12(2):1171-76.
5. Gianeti MD, Maia Campos PMBGM. Efficacy evaluation of a
multifunctional cosmetic formulation: The benefits of a combination of
active antioxidant substances. Molecules 2014;19(11):18268-82.
6. Bhasha SA, Khalid SA, Duraivel S, Bhowmik D, Kumar KPS. Recent
trends in usage of polymers in the formulation of dermatological gels.
Indian J Res Pharm Biotechnol 2013;1(2):161-68.
7. Allen LV, Ansel HC. Anselâ€™s pharmaceutical dosage forms and drug
delivery systems 10th ed. Wolter Kluwer health: United States of
America; 2014: pp.102-299.
8. Fahr A. Voigtâ€™s pharmaceutical technology 1st ed. Hoboken: John Wiley
& Sons Ltd; 2018: pp. 279-340.
9. Niazi SK. Handbook of pharmaceutical manufacturing formulations
2nd ed. Boca Raton: CRC Press; 2009.
10. Johnson DH. The use of fatty acid derivatives in cosmetics and
toiletries. J Am Oil Chem Soc 1978;55(4):438â€“43.
11. Diamante C, Fiume MZ, Bergfeld WF, Belsito DV, Hill RA,
Klaassen CD, et al. Final safety assessment of thiodipropionic acid
and its dialkyl esters as used in cosmetics. Int J Toxicol 2010;29(4):
12. Bradley, Coulier. An investigation into the reaction and breakdown
products from starting substances used to produce food contact plastic.
13. Manurung J. Drug quality assurance: Compendium guidelines and
related materials, 1st ed. Jakarta: Penerbit Buku Kedokteran EGC; 2006.
14. Bajaj S, Sakhuja N, Singla D, Bajaj Principal S. Stability testing of
pharmaceutical products. J Appl Pharm Sci 2012;2(3):129-38.
15. Fisk HL, West AL, Childs CE, Burdge GC, Calder PC. The use of gas
chromatography to analyze compositional changes of fatty acids in rat
liver tissue during pregnancy. J Vis Exp 2014;85:1-10.
16. Zhang H, Wang Z, Liu O. Development and validation of a GC-FID
method for quantitative analysis of oleic acid and related fatty acids.
J Pharm Anal 2015;5(4):223-30.
17. Harmita, MJ.Physico-chemical analysis. Jakarta: Penerbit Buku
Kedokteran EGC; 2015. [In Indonesian]
18. Carey FA, Sundberg RJ. Advanced organic chemistry part A: Structure
and mechanisms. US: Springer; 2007.
19. Stoker HS. Organic and biological chemistry 7th ed. Boston: Cengage
20. Johnson WA. Invitation to organic chemistry. London: Jones & Bartlett